149 related articles for article (PubMed ID: 3753495)
21. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.
Schlondorff D; Goldwasser P; Neuwirth R; Satriano JA; Clay KL
Am J Physiol; 1986 Jun; 250(6 Pt 2):F1123-7. PubMed ID: 3087218
[TBL] [Abstract][Full Text] [Related]
22. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
[TBL] [Abstract][Full Text] [Related]
23. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
[TBL] [Abstract][Full Text] [Related]
24. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.
Blank ML; Smith ZL; Fitzgerald V; Snyder F
Biochim Biophys Acta; 1995 Feb; 1254(3):295-301. PubMed ID: 7857969
[TBL] [Abstract][Full Text] [Related]
25. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
26. Platelet-activating factor in the rabbit uterus during early pregnancy.
Angle MJ; Jones MA; McManus LM; Pinckard RN; Harper MJ
J Reprod Fertil; 1988 Jul; 83(2):711-22. PubMed ID: 3411561
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2001 Jun; 66(6):658-61. PubMed ID: 11421815
[TBL] [Abstract][Full Text] [Related]
28. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
Nishihira J; Ishibashi T; Imai Y
J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
[TBL] [Abstract][Full Text] [Related]
29. Capillary gas chromatography and tandem mass spectrometry of paf-acether and analogs: absence of 1-O-alkyl-2-propionyl-sn-glycero-3-phosphocholine in human polymorphonuclear neutrophils.
Bossant MJ; Farinotti R; De Maack F; Mahuzier G; Benveniste J; Ninio E
Lipids; 1989 Feb; 24(2):121-4. PubMed ID: 2755300
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the enzymatic hydrolysis of acetate from alkylacetylglycerols in the de novo pathway of PAF biosynthesis.
Blank ML; Smith ZL; Cress EA; Snyder F
Biochim Biophys Acta; 1990 Feb; 1042(2):153-8. PubMed ID: 2302414
[TBL] [Abstract][Full Text] [Related]
31. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
Karasawa K; Satoh N; Masuda M; Setaka M; Hashimoto K; Ishibashi K; Nojima S
J Biochem; 1991 Nov; 110(5):683-7. PubMed ID: 1723729
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.
Triggiani M; Hubbard WC; Chilton FH
J Immunol; 1990 Jun; 144(12):4773-80. PubMed ID: 2141044
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of 1-O-alkyl-2-acetyl-sn-glycerol by washed rabbit platelets: formation of platelet activating factor.
Satouchi K; Oda M; Saito K; Hanahan DJ
Arch Biochem Biophys; 1984 Oct; 234(1):318-21. PubMed ID: 6486825
[TBL] [Abstract][Full Text] [Related]
35. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
36. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.
Kloprogge E; Hasselaar P; Akkerman JW
Biochem J; 1986 Sep; 238(3):885-91. PubMed ID: 3800968
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and proaggregatory activity of 1-O-(2-methyloctadecyl)-2-O-acetyl-rac-glycero-3-phosphocholine.
Schmid B; Ostermann G; Kertscher HP
Chem Phys Lipids; 1991 Nov; 60(1):77-82. PubMed ID: 1813180
[TBL] [Abstract][Full Text] [Related]
38. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
39. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase.
Okayasu T; Hoshii K; Seyama K; Ishibashi T; Imai Y
Biochim Biophys Acta; 1986 Mar; 876(1):58-64. PubMed ID: 3947669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
